Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 199 is classified as a pseudogene, specifically a non-coding RNA pseudogene resembling the gene encoding 7SK small nuclear RNA[2][3]. Pseudogenes like RN7SKP199 are non-functional segments of DNA related to functional genes; they do not encode active proteins or RNA molecules and lack established biological functions or disease associations. There is no evidence that RN7SKP199 acts as a therapeutic target, receptor, enzyme, or transporter[2][3]. Key points: - RN7SKP199 is not a receptor or druggable target. - It has no known biological function, role in disease, biomarkers, drug interactions, or safety concerns. - It is strictly classified as a pseudogene, and there is no indication of misspelling or incorrect naming[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 199 (RN7SKP199).